In an impressive financial turnaround, Natco Pharma, based in Hyderabad, revealed a consolidated net profit of Rs 369 crore in Q2 ending September 30, 2023, marking a substantial over six-fold increase from Rs 57 crore in the corresponding period last fiscal. The consolidated total revenue witnessed significant growth, soaring from Rs 453 crore to Rs 1,061 crore year-on-year. The outstanding performance is attributed to the company’s expansion in formulation exports and increased sales in the domestic agrochemical sector. Natco Pharma’s stellar Q2 results reflect its resilience and strategic positioning in the pharmaceutical industry, showcasing a robust financial outlook and market competitiveness.